Crisonà M, Tardo A M, Pietra M, Del Magno S, Linta N, Diana A, Muscatello L V, Peccolo G, Del Baldo F
Department of Veterinary Medical Sciences, University of Bologna, Bologna, Italy.
J Small Anim Pract. 2025 Jan;66(1):52-60. doi: 10.1111/jsap.13783. Epub 2024 Sep 5.
To describe clinical, ultrasonographic, pathological features and response to medical therapy of four dogs with intestinal lipogranulomatous lymphangitis.
Retrospective review of medical records of dogs with an ultrasonographic evidence of focal or multifocal intestinal wall thickening and a histological diagnosis of lipogranulomatous lymphangitis. Only dogs that did not undergo surgical resection of the lesions were included. The clinical response to medical treatment, consisting of low-fat or hydrolysed diet along with immunosuppressive agents was assessed; clinicopathological and ultrasonographic abnormalities were re-evaluated over time, with a median follow-up period of 16.5 months.
Four dogs met the inclusion criteria. The main historical complaints were diarrhoea (three of four dogs), vomiting (three of four dogs) and abdominal pain (two of four dogs). Clinicopathological abnormalities comprised hypoproteinaemia, hypoalbuminaemia and mild/moderate increase in C-reactive protein levels (three of four dogs). Abdominal ultrasound revealed focal (two of four dogs) or multifocal (two of four dogs) intestinal wall thickening involving distal jejunum, ileum and ileocolic junction. Histopathology of full thickness intestinal biopsies revealed granulomatous enteritis and lymphangitis with lymphangiectasia. Nutritional and medical treatment allowed complete clinical remission in all four dogs within a month of therapy. Improvement of ultrasound abnormalities was noted in three of the four dogs over a 3- to 12-month period.
Intestinal lipogranulomatous lymphangitis is a rare form of canine chronic enteropathy characterised by focal or multifocal intestinal lesions due to the presence of transmural intestinal lipogranulomas. This is the first case series describing successful management of intestinal lipogranulomatous lymphangitis through medical treatment alone.
描述四只患有肠道脂肪肉芽肿性淋巴管炎的犬的临床、超声、病理特征及药物治疗反应。
回顾性分析有超声证据显示局灶性或多灶性肠壁增厚且组织学诊断为脂肪肉芽肿性淋巴管炎的犬的病历。仅纳入未对病变进行手术切除的犬。评估由低脂或水解饮食及免疫抑制剂组成的药物治疗的临床反应;随着时间推移对临床病理和超声异常进行重新评估,中位随访期为16.5个月。
四只犬符合纳入标准。主要病史主诉为腹泻(四只犬中的三只)、呕吐(四只犬中的三只)和腹痛(四只犬中的两只)。临床病理异常包括低蛋白血症、低白蛋白血症和C反应蛋白水平轻度/中度升高(四只犬中的三只)。腹部超声显示局灶性(四只犬中的两只)或多灶性(四只犬中的两只)肠壁增厚,累及空肠远端、回肠和回盲交界处。全层肠活检的组织病理学显示肉芽肿性肠炎和淋巴管炎伴淋巴管扩张。营养和药物治疗使所有四只犬在治疗一个月内实现完全临床缓解。在3至12个月期间,四只犬中的三只超声异常有所改善。
肠道脂肪肉芽肿性淋巴管炎是一种罕见的犬慢性肠病形式,其特征是由于透壁性肠道脂肪肉芽肿的存在而出现局灶性或多灶性肠道病变。这是首个仅通过药物治疗成功管理肠道脂肪肉芽肿性淋巴管炎的病例系列。